Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

A severability clause lets certain contract parts remain valid, even if others are void. Learn about its definition, key ...

Explore disaffirmance, the legal right to void contracts. Learn who can disaffirm agreements and under what circumstances, ...